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Some cardiovascular effects of marihuana smoking 
in normal volunteers 
Marihuana smoking caused a significant increase in heart rate in 25 normal male 
volunteers. The degree of techycardia was significantly related to the dose of 1l-9-
tetrahydrocannabinol (1l-9-THC). The marihuana smoked contained 0.5 and 2.9 per 
cent 1l-9-THC and was compared to extracted marihuana as a control in a single-blind 
experimental design. Dose of 1l-9-THC was expressed as the total amount available 
in the number of cigarettes smoked under standard conditions. The tachycardia reached 
a maximum within 30 minutes and persisted longer than 90 minutes. Systolic and 
diastolic blood pressures were significantly elevated after total doses of marihuana 
containing more than 10 mg. of THC, but blood pressure was better correlated to 
heart rate than to dose. Changes in the electrocardiogram were minimal, but there 
were premature ventricular contractions in some sub;ects. 
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Many observers6 , 7, 10 have noted a sig-
nificant dose-related increase in pulse rate 
in subjects smoking marihuana. While 
studying the effects of marihuana on the 
electroencephalogram (EEG ) and on 
tests of perception and cognitive function, 
we observed premature ventricular con-
tractions in 2 healthy subjects. A search of 
previous publications on marihuana re-
vealed little detail about its cardiovascular 
effects. In view of the large number of 
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marihuana smokers of all ages and the in-
creasing interest in possible therapeutic 
uses of marilmana, we thought it impor-
tant to investigate more thoroughly its 
cardiovascular actions. 
Materials and methods 
This study was performed in two parts. 
In 1969, 10 subjects took part in a low 
dose (0.5 per cent 6.-9-tetrahydrocannabinol 
[THe]) marihuana study and then in a 
single-blind placebo (0 per cent .6.-9-THe) 
study. In early 1971, 15 different subjects 
took part in a high dose (2.9 per cent 6.-9-
THe) marihuana study. All subjects were 
men between the ages of 21 and 33. All had 
smoked marihuana previously, but only 4 
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of 10 in the low-dose study and 2 of 15 in 
the high-dose study were daily users. One 
of the subjects in the high-dose study was 
able to tolerate a large dose (30 mg. 
~-9-THC) with little change in his outward 
behavior or conversation. The other 14 
subjects reported they were "as high or 
higher than ever before" during the high-
dose marihuana study. 
The subjects received thorough medical 
histories, reviews of systems, and psychi-
atric and physical examinations. None had 
scores outside the normal range on the 
Minnesota Multiphasic Personality Inven-
tory (MMPI). None had a history of heart 
disease or hypertension, nor did they have 
elevated blood pressure readings, irregular-
ities of pulse, cardiac murmurs, abnormal 
electrocardiograms (ECG), or other evi-
dence of cardiovascular disease on physical 
examination. 
Marihuana was obtained from the Na-
tional Institute of Mental Health. The first 
batch was shown by independent analysis\) 
to contain 0.5 per cent ~-9-tetrahydrocanna­
binoI. Subsequently, it was found to con-
tain 0.2% ~-9-THC.t It was used for the 
low dose studies and arbitrarily assumed 
to contain 0.5 per cent during most of 
the study. A second batch of marihuana 
for the high dose study contained 2.9 per 
cent ~-9-THC.t All marihuana was admin-
istered as 300 mg. cigarettes which were 
smoked to the shortest possible butt. Butts 
were weighed to determine the approxi-
mate dose smoked. In the low-dose study, 
subjects smoked from 2 to 5 cigarettes. In 
the high-dose study, subjects were in-
structed to smoke until they were as high 
as they had ever been on marihuana and 
felt they could not smoke any more. This 
required from one to 4 cigarettes. Sub-
jects were told to inhale deeply and to let 
none of the smoke appear in the exhaled 
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air. No corrections were made for pyrolysis, 
exhaled smoke, and cigarette smoke burned 
but not inhaled. 
Electrocardiograms of the 3 standard 
limb leads and the six chest leads were 
obtained in the supine position before and 
within 1f2 hour after finishing the mari-
huana in 8 subjects. In 2 of the subjects, 
ECG's were also obtained after single-
blind administration of placebo extract 
marihuana on which the subjects felt sub-
jectively high and also after exercise. 
Blood pressure was measured at least 
three times before smoking marihuana to 
obtain a stable base line. It was recorded 
three times again within 1f2 hour after 
smoking. Diastolic pressure was recorded 
at the muming of the Korotkoff sound. The 
difference in means of the blood pressures 
before and after marihuana is reported 
as the change in blood pressure. 
Pulse rate was recorded from a continu-
ous polygraph record in those subjects who 
did not have complete ECG's. The change 
in pulse rate is the difference between a 
base-line rate and the highest rate ob-
tained within one hour of smoking mari-
huana. 
Results 
Our experiments show that the increase 
in heart rate after smoking marihuana is 
dose related (Fig. 1). The coefficient of 
correlation between logro dose and the in-
crease in heart rate is 0.8 for which p < 
0.001. One subject, a daily user of mari-
huana, seemed to be extremely tolerant of 
the psychic effects. However, his heart 
rate increased from 55 to 120 after a 30 
mg. dose. The marihuana-induced tachy-
cardia persists at least 90 minutes (Fig. 
2). The maximum heart rate was usually 
reached within 30 minutes after smoking 
the marihuana. 
The systolic blood pressure was signifi-
cantly elevated in subjects receiving more 
than 10 mg. of marihuana (p <0.01 on the 
Wilcoxin sign test for differences in related 
samples). The rise in systolic blood pres-
sure appeared to be dose related, although 
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Fig. 1. Dose-effect relationship of marihuana smoki~g on heart rate. Adult male volunteers 
were given various amounts of marihuana of varying 1l-9-THC content. The maximal increase 
in heart rate above control is given on the y axis and the total amount of 1l-9-THC in the 
cigarettes on the x axis. Each point represents an individual subject. The coefficient of cor-
relation is 0.8 for which p <0.001. 
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Fig. 2. Duration of marihuana-induced tachycardia in 3 different subjects. Subjects smoked 
varying amounts of 2.9 per cent ~-9-THC containing marihuana. Note the more prolonged 
heart rate increases occurred with the larger doses. 
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Fig. 3. Dose-effect relationship of marihuana smoking on arterial blood pressure. The upper 
graph illustrates the change in systolic and the lower graph the change in diastolic blood 
pressure. Each point represents a given subject as in Fig. 1. Note the trend for a slight in-
crease in blood pressure which was greater for systolic than diastolic. See text for discussion of 
the significance of these slight changes. 
the coefficient of correlation was only 0.3 
and the p value <0.10. The diastolic blood 
pressure was also significantly elevated 
after marihuana smoking (p <0.02 on the 
Wilcoxin test). For the diastolic pressure 
data the coefficient of correlation of the 
10glo dose response curve was only 0.3. 
Systolic and diastolic blood pressure data 
are shown in Fig. 3. 
The data from the single-blind placebo 
extract experiments showed no significant 
changes in heart rate or blood pressure. 
Fig. 4 shows selected portions of Leads I, 
II, and Vs of the ECG tracings, the base-
line, placebo, post-15.3 mg. Ll-9-THC, and 
post-exercise results. Smoking marihuana 
tended to flatten T waves, especially in the 
chest leads, in many subjects, but T wave 
flattening was not a constant finding. T 
wave changes induced by exercise are more 
prominent than those induced by the mari-
huana SIT',oking. Two of 15 subjects in the 
high-dose study developed premature ven-
tricular contractions ( PVC's). The PVC's 
occurred less than 1 per 25 beats after 
marihuana smoking but did not appear in 
control ECG rhythm strips of 1 to 2 min-
utes in length or on control polygraph re-
cordings. Two of the PVC's from one of 
the subjects are shown in Fig. 5. Besides 
the PVC's in 2 subjects and the tachycardia 
and frequent T wave flattening in others, 
no ECG changes were noted. 
Discussion 
Marihuana causes a significant increase 
in heart rate. 6 , 7, 10 Isbell and associates4 
and Hollister and associates3 have shown 
that Ll-9-THC produces most of the psychic 
effects of marihuana and also the tachy-
cardia. A recent report by Manno and 
associates 6 shows that the increased heart 
rate after marihuana is dose related. Our 
study also indicates a significant dose-re-
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Fig. 4. ECG changes following extracted and active marihuana compared to control and exer-
cise. A portion of each lead tracing is as shown. On different days the same subject was given 
15.8 mg. of active 2.9 per cent 6.-9-THC and extracted marihuana cigarettes as well as the 
exercise of running up a flight of stairs. Note the tachycardia after marihuana smoking com-
pared with the tachycardia of exercise. T wave changes are less marked. 
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Fig. 5. Premature ventricular contractions after marihuana smoking. During the control ses-
sions (10 min. tracing) the subject never showed PVC's but did after taking 18.9 mg. of 
2.9 per cent 6.-9-THC marihuana cigarettes. This particular record was taken one hour after 
smoking but the PVC's were seen on a polygraph record shortly after smoking as well. 
sponse relationship between the 6.-9-THC 
dose and the increased heart rate. The co-
efficient of correlation of 0.8 indicates that 
about 63 per cent of the variance in heart 
rate is associated with the dose of 6.-9-
THC in these experiments. Variability in 
heart rate response to a given dose could 
result from a number of factors. Calcula-
tion of the marihuana dosage on a milli-
gram per kilogram basis did not reduce 
the variation in the data and therefore are 
not included as a separate table. 
As indicated in the Material and Meth-
ods section, the effects of pyrolysis,4 the 
efficiency of absorption of smoke by the 
lungs, and escape of smoke from the burn-
ing cigarette were not calculated into the 
dose. The dose indicated in the figures 
is the maximum possible dose each sub-
ject could have smoked. However, we be-
lieve that the actual dose absorbed is pro-
portional to the total dose-that is, that 
losses of 6.-9-THC were similar for all 
subjects in the study. 
Volume 12 
Number 5 
A third possible explanation for variabil-
ity of response at a given dose is that some 
subjects were tolerant to marihuana." o How-
ever, the one subject able to smoke 30 
mg. of A-9-THC without feeling as high 
as he had ever been did have an increase 
of 65 beats per minute even though he 
seemed able to talk and reason as well 
as before he smoked. Hence, tolerance does 
not seem to develop as easily to the cardio-
vascular actions of marihuana as to its 
psychic effects. This is being pursued in 
another study separating subjects into toler-
ant and nontolerant groups. 
Anxiety-producing and sedative effects of 
marihuana do change the magnitude of 
the tachycardia. This mood induced by 
the dose of marihuana may account for 
most of the variability in heart rate for a 
given dose. One subject, who became 
panicky after a 25 mg. dose of A-9-THC, 
had a heart rate increase of 108. Another 
who became somnolent after 25 mg. had 
a heart rate increase of only 36. 
Other investigators 3 , 4, 10 have noted 
variable blood pressure changes after mari-
huana smoking. With low doses of A-9-
THC, we noted no significant changes in 
blood pressure.9 At doses above 10 mg. 
we noted significant increases in both 
systolic and diastolic blood pressures. 
Whether the changes in blood pressure are 
dose related is difficult to say. The coeffi-
cients of correlation of blood pressure and 
log dose are low. The changes in blood 
pressure correlated better with tachycardia 
than with dose of .A-9-THC: for increase 
in heart rate versus increase in systolic 
pressure, r = 0.381, P <0.07. 
Concerning changes in the electrocardio-
grams, we observed premature ventricular 
contractions in 2 of 15 subjects receiving 
10 mg. or more of marihuana. The sub-
jects themselves were unaware of them. 
Flattening of T waves was observed, espe-
cially in the chest leads, but this was 
neither a constant nOr a specific finding. 
That ECG changes are minor after mari-
huana agrees with the conclusions of the 
LaGuardia Study7 and the study by Hol-
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lister and associates. 3 The latter reported 
uniformly negative ECG's in patients who 
received large oral doses of A-9-THC or 
pyrahexyI. This difference might indicate 
that the effects were related to smoking 
rather than to a pharmacological effect 
of THC. 
The mechanism of the cannabis tachy-
cardia remains unclear. The PVC's we ob-
served may implicate catecholamine re-
lease. However, dry mouth, suggesting an 
atropine-like effect, and conjunctival in-
jection, suggesting a vasodilatory action, 
are also present. 'Ve attempted to produce 
a cannabis tachycardia in an unanesthe-
tized dog paralyzed with decamethonium. 
After intravenous doses of A-9-THC from 
0.32 to 3.2 mg. per kilogram we observed 
electroencephalographic slowing and also 
hypotension and bradycardia. Species dif-
ferences in the cardiovascular effects and 
the augmentation of the tachycardia by 
anxiety and its reduction by sedation, sug-
gest that the cannabis tachycardia is medi-
ated through the central nervous system. 
Although no deaths have been reported 
from marihuana intoxication alone,5 the 
tachycardia, hypertension, and PVC's it 
can produce indicate that marihuana 
should be used with caution by people 
with heart disease. Like nicotine and caf-
feine, marihuana may be a cause of PVC's 
in susceptible individuals. This was a rela-
tively rare finding and may be due to 
smoking rather than to pure A-9-THC. 
The two susceptible subjects merely had 
a "before" control tracing which did not 
show PVC's but did "after." Further studies 
are clearly indicated, for marihuana smoke 
contains many other chemical substances. 
The clinical significance of our finding is 
probably no greater than that for suscep-
tible subjects now smoking tobacco and 
drinking caffeine-containing beverages. 2 
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